For agencies

Working with public health programmes.

For national vector control agencies, ministries of health, and institutional partners exploring Wolbachia-based vector-borne disease control in Southeast Asia.

The problem we address

Dengue remains one of SEA's most persistent public health burdens.

Southeast Asia accounts for a disproportionate share of global dengue cases. Urban growth, changing rainfall patterns, and expanding Aedes habitats have sustained or increased transmission in many countries, despite decades of vector control effort.

Insecticide resistance in Ae. aegypti populations is well-documented across the region. Operational costs are sustained and recurring.

Wolbachia-based biocontrol is not a replacement for existing vector management. It is a complementary, non-chemical tool with a growing evidence base, and with the production infrastructure now available, it is deployable within real government programmes.

Non-chemical

No pesticide. No genetic modification. Wolbachia is a naturally occurring bacterium. The mosquitoes we release are not GMOs.

Addresses disease transmission directly

Suppression programmes reduce the local mosquito population. Replacement programmes reduce the mosquito's capacity to transmit dengue virus. Both strategies target transmission risk at source.

Cost-effective at programme scale

Suppression programmes offer a scalable, non-chemical alternative to recurring insecticide operations. Replacement programmes, once established, are self-sustaining, reducing ongoing input requirements over time.

What we offer

An end-to-end partnership configured for your programme.

We design, establish, and operate a complete Wolbachia biocontrol system built around your country, your regulatory environment, and your programme objectives.

Feasibility assessment

Evaluation of suitability for your setting: species profiling, geographic assessment, regulatory landscape review, and programme design options.

Production setup

Design, establishment, and operational support for in-country rearing and sex-sorting facilities, scalable from pilot to full programme capacity.

Release programme design

Protocol development for suppression (IIT) or replacement, covering release density, scheduling, zone coverage, and integration with existing operations.

Regulatory support

Guidance through national and regional approval frameworks, with documentation support for programme authorisation.

Release and evaluation

Release scheduling and logistics, field monitoring system design, trap network setup, and ongoing programme evaluation to track suppression outcomes.

Who we work with

Government agencies and institutional partners.

National health agencies

Ministries of health and national vector control bodies exploring non-chemical interventions for dengue. We work at national programme scale.

City and municipal bodies

Sub-national public health authorities managing vector control in specific zones, particularly cities with sustained dengue burden.

Institutional partners

Development finance bodies, international public health organisations, and research institutions supporting Wolbachia biocontrol capability development in the region.

How to begin

From first conversation to programme design.

Every engagement begins with a briefing: a structured conversation about your programme context, objectives, regulatory environment, and timeline. No commitment is required at this stage.

Useful context to bring

  • Which dengue vectors are present in your target area

  • Geographic scope and urban/peri-urban character

  • Existing vector control operations and infrastructure

  • Regulatory environment for novel biocontrol methods

  • Programme timeline and funding structure

01

Initial briefing

A structured conversation about your setting: target species, geographic scope, disease burden, regulatory environment, and existing operations. No commitment required.

02

Feasibility assessment

A detailed written review of whether Wolbachia biocontrol is appropriate for your context, covering production requirements, regulatory pathway, and programme design options.

03

Programme design

Co-development of a full programme design covering strain selection, production infrastructure, release protocol, regulatory pathway, monitoring system, and phasing plan.

04

Pilot programme

Establishment of production capability, regulatory engagement, and launch of a defined pilot with agreed monitoring criteria and decision points for scale-up.

05

Scale and capability transfer

Expansion of programme coverage, training of in-country teams, and progressive transfer of production and programme management capability to the implementing agency.

Beyond public health

Wolbachia for agricultural pest control

Protecting crops from virus-transmitting insects.

Explore →

Get started

Request a briefing to begin the conversation

We respond to all agency and institutional enquiries within two business days. No commitment is required at the briefing stage.

Contact us directly